Edwards Lifesciences Cost of Goods Sold 2010-2024 | EW
Edwards Lifesciences annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Edwards Lifesciences cost of goods sold for the quarter ending September 30, 2024 was $0.263B, a 4.91% increase year-over-year.
- Edwards Lifesciences cost of goods sold for the twelve months ending September 30, 2024 was $1.477B, a 34.86% increase year-over-year.
- Edwards Lifesciences annual cost of goods sold for 2023 was $1.38B, a 27.71% increase from 2022.
- Edwards Lifesciences annual cost of goods sold for 2022 was $1.08B, a 13.49% decline from 2021.
- Edwards Lifesciences annual cost of goods sold for 2021 was $1.249B, a 15.57% increase from 2020.
| Edwards Lifesciences Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $1,380 |
| 2022 | $1,080 |
| 2021 | $1,249 |
| 2020 | $1,081 |
| 2019 | $1,114 |
| 2018 | $939 |
| 2017 | $875 |
| 2016 | $797 |
| 2015 | $617 |
| 2014 | $626 |
| 2013 | $517 |
| 2012 | $491 |
| 2011 | $490 |
| 2010 | $408 |
| 2009 | $399 |
| Edwards Lifesciences Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $263 |
| 2024-06-30 | $285 |
| 2024-03-31 | $386 |
| 2023-12-31 | $543 |
| 2023-09-30 | $251 |
| 2023-06-30 | $257 |
| 2023-03-31 | $330 |
| 2022-12-31 | $258 |
| 2022-09-30 | $254 |
| 2022-06-30 | $269 |
| 2022-03-31 | $299 |
| 2021-12-31 | $310 |
| 2021-09-30 | $312 |
| 2021-06-30 | $334 |
| 2021-03-31 | $293 |
| 2020-12-31 | $296 |
| 2020-09-30 | $281 |
| 2020-06-30 | $238 |
| 2020-03-31 | $265 |
| 2019-12-31 | $286 |
| 2019-09-30 | $292 |
| 2019-06-30 | $304 |
| 2019-03-31 | $232 |
| 2018-12-31 | $235 |
| 2018-09-30 | $225 |
| 2018-06-30 | $246 |
| 2018-03-31 | $234 |
| 2017-12-31 | $235 |
| 2017-09-30 | $213 |
| 2017-06-30 | $211 |
| 2017-03-31 | $216 |
| 2016-12-31 | $213 |
| 2016-09-30 | $201 |
| 2016-06-30 | $203 |
| 2016-03-31 | $180 |
| 2015-12-31 | $176 |
| 2015-09-30 | $147 |
| 2015-06-30 | $159 |
| 2015-03-31 | $136 |
| 2014-12-31 | $160 |
| 2014-09-30 | $168 |
| 2014-06-30 | $151 |
| 2014-03-31 | $146 |
| 2013-12-31 | $144 |
| 2013-09-30 | $128 |
| 2013-06-30 | $124 |
| 2013-03-31 | $121 |
| 2012-12-31 | $122 |
| 2012-09-30 | $112 |
| 2012-06-30 | $130 |
| 2012-03-31 | $127 |
| 2011-12-31 | $120 |
| 2011-09-30 | $126 |
| 2011-06-30 | $128 |
| 2011-03-31 | $117 |
| 2010-12-31 | $114 |
| 2010-09-30 | $96 |
| 2010-06-30 | $100 |
| 2010-03-31 | $99 |
| 2009-12-31 | $102 |
| 2009-09-30 | $99 |
| 2009-06-30 | $102 |
| 2009-03-31 | $97 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $42.814B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $199.883B | 24.39 |
| Intuitive Surgical (ISRG) | United States | $186.649B | 97.58 |
| Alcon (ALC) | Switzerland | $41.161B | 27.54 |
| IQVIA Holdings (IQV) | United States | $35.414B | 19.51 |
| IDEXX Laboratories (IDXX) | United States | $33.479B | 39.43 |
| DexCom (DXCM) | United States | $30.662B | 46.18 |
| Waters (WAT) | United States | $21.866B | 32.33 |
| STERIS (STE) | Ireland | $19.984B | 23.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.343B | 0.00 |
| Hologic (HOLX) | United States | $16.281B | 17.58 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.998B | 13.34 |
| Sysmex ADR (SSMXY) | Japan | $11.450B | 35.90 |
| Globus Medical (GMED) | United States | $11.143B | 28.22 |
| Penumbra (PEN) | United States | $9.211B | 90.22 |
| Masimo (MASI) | United States | $9.025B | 43.67 |
| Teleflex (TFX) | United States | $8.316B | 13.26 |
| Glaukos (GKOS) | United States | $8.253B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.433B | 25.13 |
| PROCEPT BioRobotics (PRCT) | United States | $4.340B | 0.00 |
| Veracyte (VCYT) | United States | $3.134B | 94.05 |
| Inari Medical (NARI) | United States | $3.033B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.533B | 14.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.354B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.318B | 17.61 |
| TransMedics (TMDX) | United States | $2.232B | 70.75 |
| Elekta AB (EKTAY) | Sweden | $2.095B | 18.83 |
| Integra LifeSciences Holdings (IART) | United States | $1.776B | 9.28 |
| RxSight (RXST) | United States | $1.393B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.285B | 0.00 |
| Artivion (AORT) | United States | $1.177B | 78.00 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| Paragon 28 (FNA) | United States | $0.897B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.728B | 12.37 |
| AxoGen (AXGN) | United States | $0.722B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.90 |
| IRadimed (IRMD) | United States | $0.696B | 37.63 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.660B | 0.00 |
| SiBone (SIBN) | United States | $0.584B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.554B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.506B | 26.63 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.490B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.411B | 22.23 |
| Delcath Systems (DCTH) | United States | $0.403B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.365B | 0.00 |
| NeuroPace (NPCE) | United States | $0.346B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Nevro (NVRO) | United States | $0.139B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| LENSAR (LNSR) | United States | $0.101B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.099B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Neuronetics (STIM) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |